CVRx (CVRX) Competitors $7.24 -0.09 (-1.16%) As of 01:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. AXGN, EMBC, IRMD, SIBN, BVS, RXST, BFLY, AVNS, CBLL, and KIDSShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), SI-BONE (SIBN), Bioventus (BVS), RxSight (RXST), Butterfly Network (BFLY), Avanos Medical (AVNS), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. CVRx vs. AxoGen Embecta Iradimed SI-BONE Bioventus RxSight Butterfly Network Avanos Medical CeriBell OrthoPediatrics AxoGen (NASDAQ:AXGN) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings. Do analysts rate AXGN or CVRX? AxoGen currently has a consensus price target of $22.60, suggesting a potential upside of 34.16%. CVRx has a consensus price target of $17.60, suggesting a potential upside of 143.26%. Given CVRx's higher probable upside, analysts plainly believe CVRx is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00CVRx 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, AXGN or CVRX? AxoGen has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, CVRx has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Which has stronger valuation & earnings, AXGN or CVRX? AxoGen has higher revenue and earnings than CVRx. AxoGen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M3.99-$21.72M-$0.22-76.57CVRx$51.29M3.68-$59.97M-$2.69-2.69 Does the MarketBeat Community believe in AXGN or CVRX? AxoGen received 422 more outperform votes than CVRx when rated by MarketBeat users. However, 74.47% of users gave CVRx an outperform vote while only 72.89% of users gave AxoGen an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45772.89% Underperform Votes17027.11% CVRxOutperform Votes3574.47% Underperform Votes1225.53% Is AXGN or CVRX more profitable? AxoGen has a net margin of -7.91% compared to CVRx's net margin of -116.91%. AxoGen's return on equity of -14.91% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% CVRx -116.91%-93.06%-51.78% Does the media favor AXGN or CVRX? In the previous week, AxoGen had 2 more articles in the media than CVRx. MarketBeat recorded 7 mentions for AxoGen and 5 mentions for CVRx. AxoGen's average media sentiment score of 1.33 beat CVRx's score of 1.11 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in AXGN or CVRX? 80.3% of AxoGen shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 7.0% of AxoGen shares are held by company insiders. Comparatively, 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryAxoGen beats CVRx on 11 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$189.12M$4.33B$5.49B$7.94BDividend YieldN/A39.94%5.11%4.23%P/E Ratio-2.7030.4822.5818.55Price / Sales3.6855.07397.25103.00Price / CashN/A51.0838.1834.62Price / Book2.656.046.704.26Net Income-$59.97M$68.71M$3.23B$248.39M7 Day Performance11.65%-0.48%1.26%1.27%1 Month Performance-42.26%-2.60%3.75%3.85%1 Year Performance-28.51%22.52%15.78%5.23% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx3.1125 of 5 stars$7.24-1.2%$17.60+143.3%-52.8%$189.12M$51.29M-2.70160Upcoming EarningsShort Interest ↓News CoveragePositive NewsAXGNAxoGen2.8984 of 5 stars$16.18-1.3%$22.60+39.7%+153.8%$717.49M$187.34M-50.56450Positive NewsEMBCEmbecta4.5882 of 5 stars$12.32+3.7%$20.33+65.0%+20.3%$716.21M$1.11B12.321,900Positive NewsIRMDIradimed4.8043 of 5 stars$53.02-0.6%$72.00+35.8%+29.1%$674.15M$73.24M35.35110Positive NewsSIBNSI-BONE4.1734 of 5 stars$14.47+0.4%$24.40+68.6%-4.3%$614.30M$167.18M-15.73350Upcoming EarningsNews CoveragePositive NewsBVSBioventus3.279 of 5 stars$7.43-2.9%$15.00+101.9%+84.6%$608.84M$573.28M-12.181,200Positive NewsRXSTRxSight2.6454 of 5 stars$14.56-2.6%$37.60+158.2%-71.8%$591.43M$139.93M-17.54220Upcoming EarningsBFLYButterfly Network2.5531 of 5 stars$2.43-0.4%$3.00+23.5%+198.6%$590.30M$82.06M-5.28460Upcoming EarningsInsider TradeNews CoverageGap UpAVNSAvanos Medical2.164 of 5 stars$12.68+2.7%N/A-30.6%$583.32M$687.80M37.294,040Upcoming EarningsShort Interest ↑Analyst RevisionHigh Trading VolumeCBLLCeriBell2.2024 of 5 stars$16.19+5.7%$32.50+100.7%N/A$580.70M$65.44M0.00N/ANews CoveragePositive NewsKIDSOrthoPediatrics4.1396 of 5 stars$21.77+1.1%$37.00+70.0%-29.7%$528.73M$204.73M-17.70200Upcoming EarningsPositive News Related Companies and Tools Related Companies AXGN Competitors EMBC Competitors IRMD Competitors SIBN Competitors BVS Competitors RXST Competitors BFLY Competitors AVNS Competitors CBLL Competitors KIDS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.